On the one hand, it was shown that an altered MBP85–99 peptide induces Th2 cytokine secretion by MBP-reactive T cells isolated from the peripheral blood of MS patients while on the other hand, it can induce disease in some patients by activating these MBP-reactive T cells against the patient’s own tissues (99). Here, MBP is linked to myeloid sarcoma.